- Home
- CLLS vs QNC Comparison
CLLS vs QNC Comparison
Compare CLLS & QNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLLS | QNC |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | France | Canada |
| Employees | N/A | 5 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 434.7M |
| IPO Year | 2014 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CLLS | QNC |
|---|---|---|
| Price | $3.35 | $2.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | 36.3K | ★ 1.1M |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.98 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.62 | $1.90 |
| 52 Week High | $5.48 | $3.59 |
Technical Indicators
Market Signals| Indicator | CLLS | QNC |
|---|---|---|
| Relative Strength Index (RSI) | 55.42 | 47.19 |
| Support Level | $2.86 | $2.63 |
| Resistance Level | $3.41 | $3.01 |
| Average True Range (ATR) | 0.16 | 0.24 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 86.96 | 11.59 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About QNC Quantum eMotion Corp. Common Shares
Quantum eMotion Inc is dedicated to developing of a new generation of quantum-safe encryption for the quantum computing age. It is a developer of a new generation of cryptographic solutions under the acquisition of licenses. It allows clients and partners to develop secure quantum-safe encryption that can protect anything from consumer and enterprise devices like mobile phones, computers, the Internet of Things, and networking equipment to demanding cloud-based applications, servers, and military devices.